These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11051806

  • 21. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH, Bondeli C, Marbet GA, Duckert F.
    Thromb Haemost; 1980 Oct 31; 44(2):92-5. PubMed ID: 7455997
    [Abstract] [Full Text] [Related]

  • 22. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T.
    Thromb Res; 1984 Dec 15; 36(6):633-42. PubMed ID: 6084876
    [Abstract] [Full Text] [Related]

  • 23. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM, Tapon-Bretaudiere J, Bros A, Josso F.
    Thromb Haemost; 1981 Feb 23; 45(1):51-4. PubMed ID: 6166063
    [Abstract] [Full Text] [Related]

  • 24. Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II.
    Tollefsen DM, Sugimori T, Maimone MM.
    Semin Thromb Hemost; 1990 Oct 23; 16 Suppl():66-70. PubMed ID: 1962908
    [Abstract] [Full Text] [Related]

  • 25. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
    Tran TH, Zbinden B, Lämmle B, Duckert F.
    Semin Thromb Hemost; 1985 Oct 23; 11(4):342-6. PubMed ID: 3840916
    [Abstract] [Full Text] [Related]

  • 26. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T, Raddatz-Mueller P, Fehr J.
    Am J Obstet Gynecol; 2001 Feb 23; 184(3):382-9. PubMed ID: 11228491
    [Abstract] [Full Text] [Related]

  • 27. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
    Dupouy D, Sié P, Dol F, Boneu B.
    Thromb Haemost; 1988 Oct 31; 60(2):236-9. PubMed ID: 3217919
    [Abstract] [Full Text] [Related]

  • 28. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 31; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb 31; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA, Liapina LA, Pastorova VE.
    Vopr Med Khim; 1988 Feb 31; 34(2):38-42. PubMed ID: 3400189
    [Abstract] [Full Text] [Related]

  • 34. Postclotting fates of thrombin.
    Seegers WH.
    Semin Thromb Hemost; 1986 Jul 31; 12(3):181-3. PubMed ID: 3775386
    [Abstract] [Full Text] [Related]

  • 35. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E, Oliver A, Félez J, Barceló P, Fernandez C, Ballarin JA, Fontcuberta J, Rutllant ML.
    Thromb Haemost; 1988 Oct 31; 60(2):137-40. PubMed ID: 3217913
    [Abstract] [Full Text] [Related]

  • 36. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits.
    Fernandez FA, Buchanan MR, Hirsh J, Fenton JW, Ofosu FA.
    Thromb Haemost; 1987 Jun 03; 57(3):286-93. PubMed ID: 3116701
    [Abstract] [Full Text] [Related]

  • 37. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM, Glass S, Quandt E, Famulok M.
    Biosens Bioelectron; 2005 Apr 15; 20(10):2044-52. PubMed ID: 15741074
    [Abstract] [Full Text] [Related]

  • 38. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB, Newton GR, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 1995 Apr 15; 20(1):73-7. PubMed ID: 7588997
    [Abstract] [Full Text] [Related]

  • 39. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
    Dol F, Sié P, Dupouy D, Boneu B.
    Thromb Haemost; 1986 Dec 15; 56(3):295-8. PubMed ID: 2436330
    [Abstract] [Full Text] [Related]

  • 40. [The second cofactor of heparin].
    Sie P.
    Ann Biol Clin (Paris); 1987 Dec 15; 45(2):181-3. PubMed ID: 3619144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.